Let’s start up with the current stock price of Global Cord Blood Corporation (CO), which is $4.61 to be very precise. The Stock rose vividly during the last session to $4.44 after opening rate of $4.40 while the lowest price it went was recorded $4.22 before closing at $4.35.
Recently in News on February 19, 2021, Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2021 Financial Results. Earnings Call Scheduled for 8:00 a.m. ET on February 25, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Global Cord Blood Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.66 on 02/17/21, with the lowest value was $3.72 for the same time period, recorded on 01/04/21.
Global Cord Blood Corporation (CO) full year performance was -2.03%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Global Cord Blood Corporation shares are logging -1.07% during the 52-week period from high price, and 81.50% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.54 and $4.66.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 221425 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Global Cord Blood Corporation (CO) recorded performance in the market was 17.25%, having the revenues showcasing 3.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 540.66M, as it employees total of 1260 workers.
The Analysts eye on Global Cord Blood Corporation (CO)
During the last month, 0 analysts gave the Global Cord Blood Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.92, with a change in the price was noted +1.28. In a similar fashion, Global Cord Blood Corporation posted a movement of +37.98% for the period of last 100 days, recording 162,988 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Global Cord Blood Corporation (CO)
Raw Stochastic average of Global Cord Blood Corporation in the period of last 50 days is set at 99.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 98.83%. In the last 20 days, the company’s Stochastic %K was 77.52% and its Stochastic %D was recorded 79.43%.
Considering, the past performance of Global Cord Blood Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 17.25%. Additionally, trading for the stock in the period of the last six months notably improved by 22.19%, alongside a downfall of -2.03% for the period of the last 12 months. The shares increased approximately by 0.23% in the 7-day charts and went down by 10.13% in the period of the last 30 days. Common stock shares were driven by 3.57% during last recorded quarter.